Editorial |
From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
Correspondence to Joanne S. Ingwall, PhD, NMR Laboratory, Brigham and Women's Hospital, 221 Longwood Ave, Room 247, Boston, MA 02115. E-mail ingwall@bustoff.bwh.harvard.edu
Key Words: nitric oxide oxygen consumption ATP synthesis heart metabolic substrate
NO is a free radical gas, NO
, in
equilibrium with the closely related redox forms
NO- and NO+. With a
molecular weight of only 30 Da/mol (for reference, molecular oxygen is
32 Da/mol), NO is readily diffusible. The half-life of NO is 0.1 to 5
seconds. NO synthesis is catalyzed by a family of proteins, NO
synthases (NOSs). The NOS originally described as the source of NO in
conduit vessel endothelial cells (eNOS or NOS3) has
been found in the endothelium of the endocardium and
the coronary vasculature, in atrial and ventricular
myocytes, and in conduction cells of the heart.1 2 3
Because NO is readily diffusible, it can affect many molecular targets. Molecular oxygen is itself a target, forming NO2, which in turn forms NO2-, and NO3-. NO reacts with the free radical superoxide O2- to form the highly reactive species peroxynitrite ONOO-. NO also reacts with iron to form Fe2+NO complexes and with amino, thiol, diazo, and tyrosyl groups in proteins. On the basis of this chemistry, the macromolecular targets of NO and its derivatives in cells can be understood. For example, activation of the signal transduction protein guanylyl cyclase occurs via NO binding to its heme. Inhibition of creatine kinase and some of the glycolytic proteins, including GAPDH, by NO occurs by binding to labile reactive -SH groups. Thus, NO functions to alter macromolecular function in 2 distinct ways: by direct chemical modification and by activation of the guanylyl cyclase signaling pathway.
NO and ATP Synthesis
NO
This article has been cited by other articles:
![]() |
E. A. Bacha, F. J. Zimmerman, V. Mor-Avi, L. Weinert, J. P. Starr, L. Sugeng, and R. M. Lang Ventricular Resynchronization by Multisite Pacing Improves Myocardial Performance in the Postoperative Single-Ventricle Patient Ann. Thorac. Surg., November 1, 2004; 78(5): 1678 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Nelson, R. D. Berger, B. J. Fetics, M. Talbot, J. C. Spinelli, J. M. Hare, and D. A. Kass Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block Circulation, December 19, 2000; 102(25): 3053 - 3059. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Sun, J. R. Falck, H. Okamoto, D. R. Harder, and R. J. Roman Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H339 - H350. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |